02.05.10
Scott Canute has joined Genzyme as head of manufacturing and corporate operations. Mr. Canute was previously manufacturing head at Eli Lilly & Co. He also served as president of global manufacturing and corporate operations, where he over saw the production of a diverse range of products manufactured at 17 sites around the world.
“Scott Canute is among the very top people in the pharmaceutical manufacturing field,” said Henri A. Termeer, Genzyme’s chairman and chief executive officer. “He is widely respected for transforming manufacturing operations at Lilly and establishing its programs as a standard for the industry. His experience will accelerate efforts to strengthen our manufacturing sites, and consistently meet world-class standards.”
Genzyme has also named Ron Branning senior vice president of global product quality. The new leadership positions in Manufacturing and Quality are part of the company’s strategic plan to strengthen its global manufacturing operations.
“Scott Canute is among the very top people in the pharmaceutical manufacturing field,” said Henri A. Termeer, Genzyme’s chairman and chief executive officer. “He is widely respected for transforming manufacturing operations at Lilly and establishing its programs as a standard for the industry. His experience will accelerate efforts to strengthen our manufacturing sites, and consistently meet world-class standards.”
Genzyme has also named Ron Branning senior vice president of global product quality. The new leadership positions in Manufacturing and Quality are part of the company’s strategic plan to strengthen its global manufacturing operations.